Vascular Biology and RAAS:
Past, Present & Future
Victor J. Dzau, MD
Duke University Medical Center
Durham, North Carolina
|
Warburg Effect in Dysfunctional
Endothelial Cells
Michael S. Goligorsky, MD, PhD
New York Medical College
Valhalla, New York
|
Adaptive Immunity in Obesity
and Atherosclerosis
Peter Libby, MD, FACC
Harvard Medical School
Boston, Massachusetts
|
New Insights into Modulation of Angiogenesis: Role of Endothelial Progenitor Cells
John P. Cooke, MD, PhD, FACC
Stanford University School of Medicine
Stanford, University
|
|
|
|
|
|
|
|
Clopidogrel and Proton Pump Inhibitors
Eric D. Peterson, MD, MPH, FACC, FAHA
Duke University Medical Center
Durham, North Carolina
|
Evolving Antiarrhythmic Strategies in
Atrial Fibrillation
Eric N. Prystowsky, MD, FACC, FAHA
St. Vincent Hospital
Indianapolis, Indiana
|
Thrombosis and Obesity: Mechanisms and New Therapeutic Targets
Douglas E. Vaughan, MD, FACC
Northwestern University
Chicago, Illinois
|
Platelet Reactivity: Science and Clinical Practice
Stephen D. Wiviott, MD
Harvard Medical School
Boston, Massachusetts
|
|
|
|
More than One Pathway to Atherosclerosis
Andrew P. Selwyn, MD, FRCP, FACC
Harvard Medical School
Boston, Massachusetts
|
Survival and Neurologic Recovery
in Patients with ST-Elevation Myocardial Infarction
Resuscitated from Cardiac Arrest
William S. Weintraub, MD, FACC
Christiana Care Health System
Newark, Delaware
|
Direct Lp-PLA2 Inhibition and Plaque Stability
Patrick W. Serruys, MD, PhD
Erasmus Medical Center
Rotterdam, The Netherlands
|
|
|
|